Poongjeon Pharmacy CO.,LTD. (KOSDAQ:298060)
South Korea
· Delayed Price · Currency is KRW 4,635.00
+95.00 (2.09%)
At close: Apr 22, 2026
KOSDAQ:298060 Revenue
Poongjeon Pharmacy CO.,LTD. had revenue of 638.80M KRW in the quarter ending June 30, 2025, with 139.55% growth. This brings the company's revenue in the last twelve months to 1.54B, up 53.75% year-over-year. In the year 2024, Poongjeon Pharmacy CO.,LTD. had annual revenue of 824.80M with 18.56% growth.
Revenue (ttm)
1.54B
Revenue Growth
+53.75%
P/S Ratio
26.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
40.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 824.80M | 129.10M | 18.56% |
| Dec 31, 2023 | 695.70M | 299.72M | 75.69% |
| Dec 31, 2022 | 395.98M | -43.28M | -9.85% |
| Dec 31, 2021 | 439.26M | 119.26M | 37.27% |
| Dec 31, 2020 | 320.01M | 151.51M | 89.92% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Parataxis Korea | 9.00M |
| MOA Life Plus | 11.22B |
| Kainos Medicine | 1.17B |
| Eutilex.Co.,Ltd | 10.29B |
| Epibiotech | 449.62M |
| J2KBIO | 32.97B |
| NGeneBio | 21.24B |
| ADBiotech | 12.90B |